Stanford University
Showing 1,901-1,910 of 36,204 Results
-
Narges Baniasadi
Academic Staff - Hourly - CSL, Medicine - Stanford Prevention Research Center
BioDr. Narges Baniasadi is founder and executive director of Emergence program at Stanford. She develops educational and translational programs for improving societal health through entrepreneurship. She is also Adjunct Professor with the Department of Medicine where she teaches impact entrepreneurship in the areas related to Prevention and Health Equity. Narges has led multiple initiatives and businesses in the intersection of Technology and Life Sciences for more than a decade. She founded Bina, a pioneering Bioinformatics company, out of a decade of research at Stanford and UC Berkeley. Bina developed high performance computing platforms and AI solutions for cancer research and genomics analysis. Later, upon acquisition of Bina by Roche, she led the clinical software development and AI research as VP of Informatics at Roche Sequencing until 2018.
-
Batoul Banihashemi
Postdoctoral Scholar, Physics
BioResearch interests: quantum gravity, holography
-
Steven Banik
Assistant Professor of Chemistry
BioSteven Banik’s research interests center on rewiring mammalian biology and chemical biotechnology development using molecular design and construction. Projects in the Banik lab combine chemical biology, organic chemistry, protein engineering, cell and molecular biology to precisely manipulate the biological machines present in mammalian cells. Projects broadly aim to perform new functions that shed light on regulatory machinery and the potential scope of mammalian biology. A particular focus is the study of biological mechanisms that can be coopted by synthetic molecules (both small molecules and proteins). These concepts are applied to develop new therapeutic strategies for treating aging-related disorders, genetic diseases, and cancer.
Prior to joining the faculty at Stanford, Steven was a NIH and Burroughs CASI postdoctoral fellow advised by Prof. Carolyn Bertozzi at Stanford. His postdoctoral research developed approaches for targeted protein degradation from the extracellular space with lysosome targeting chimeras (LYTACs). He received his Ph.D. from Harvard University in 2016, where he worked with Prof. Eric Jacobsen on synthetic methods for the selective, catalytic difluorination of organic molecules and new approaches for generating and controlling reactive cationic intermediates in asymmetric catalysis.
